Rtw Investments, LP Exagen Inc. Transaction History
Rtw Investments, LP
- $6.13 Billion
- Q4 2024
A detailed history of Rtw Investments, LP transactions in Exagen Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 1,511,866 shares of XGN stock, worth $5.71 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
1,511,866
Previous 1,511,866
-0.0%
Holding current value
$5.71 Million
Previous $4.67 Million
32.69%
% of portfolio
0.1%
Previous 0.07%
Shares
15 transactions
Others Institutions Holding XGN
# of Institutions
43Shares Held
6.05MCall Options Held
1.1KPut Options Held
6.4K-
Toronto Dominion Bank Toronto, Ontario, A6891KShares$3.37 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY535KShares$2.02 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$1.86 Million0.0% of portfolio
-
Morgan Stanley New York, NY484KShares$1.83 Million0.0% of portfolio
-
Perkins Capital Management Inc424KShares$1.6 Million1.67% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $61.5M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...